Companies / Albania
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Actavis Targets The Balkans
May 2007 | FDI AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Icelandic generics firm Actavis is rolling out its plan to develop business in the under-penetrated, but growing markets of the Balkans region. The company has simultaneously opened an office in Albania and donated a collection of medicines to two clinics in the Republic of Macedonia. BMI believes that both developments are prescient. The former is practical, enabling operations in the region to be controlled from a hub near the region's geographical centre. Meanwhile, the latter move is more esoteric but just as important. By establishing the company's social awareness ahead of market penetration, consumers and healthcare professionals are more likely